Dexamethasone steroid – a major breakthrough in treating Covid-19

Dexamethasone, a cheap genetic steroid has proven to become the first life-saving drug treatment in the Covid-19 pandemic. The low-dose steroid treatment Dexamethasone is part of the world’s biggest trial testing existing treatments to see if they also work for coronavirus, and found it cut the risk of death by a  third for patients on…

Novartis joins the accelerated COVID-19 (ACTIV) initiative

Novartis commits to donating up to 130million doses of Hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related drug Chloroquine are currently under evaluation in clinical trials for the treatment of COVID-19. Novartis COVID-19 Response Fund of  USD 20 million, helped to build drug discovery and development collaborations and essential medicines price…

Testing started for coronavirus vaccine

In February Moderna Therapeutics, Cambridge-based (near Boston) biotech group, smashed a record for the fastest time between identifying a virus ( Covid-19) and creating a vaccine ready to test on humans in 42 days. Juan Andres, a former Novartis executive to help it ramp up manufacturing of its experimental drugs and vaccine at the new…

Thermo Fishers acquires Dutch diagnostics group Qiagen for $11.5bn

The  US Scientific equipment maker, Thermo Fisher with a market capitalisation of $122bn, has agreed to buy Dutch diagnostics group Qlagen for $11.5bn in a move to extend their disease testing capabilities as the world is gripped by the Coronavirus outbreak. Qiagen, a provider for sample and Assay technologies for molecular diagnostics, applied testing, academic…

Headache for Nurofen owner as they lose £5bn

Nurofen-Dettol and Durex owner Reckitt Benckiser have a headache as Reckitt posted a £3.7 billion loss yesterday as it took a £5 billion charge on its takeover of baby formula maker Mead  Johnson. Reckitt which also owns Cillit Bang acquired baby milk maker Mead Johnson in a mammoth £13 billion ($16.6 billion) deal in 2017.…

Recipharm to buy Consort for £505m

Consort Medical, medical devices makers was snapped up today by a Swedish rival Recipharm for £505m, delivering a boost to City Investors. Consort Medical whose brands include Besapk Asthma inhalers. ASIC medicine making facility and disposable syringes has eight manufacturing sites across the UK and employs over 2000 staff. The bid is a 39 per…

Walgreen b oots owner in $70bn deal to go private

Walgreens Boots Alliance has held talks with a private equity group on a $70bn deal to go private. Aggressive deal making by Stefano Pessina the Italian billionaire who owns 16 per cent of the global pharmacy group has assembled a business that spans 25 countries and generates  $34bn in revenues. Shares in the company rose…

Pfizer and Mylan drugs patent merger

Pfizer is expected to announce today that it will combine its off-patent drug business with Mylan, the generics drugmaker with a market value of $9.5bn.  The US drugmaker is expected to create a new unit with larger seller of off-patent and generic medicines including Lipitor and Viagra. Mylan shareholders  will hold just over 40 per…

Welsh scientist on the forefront of Stem cell cure for blindness

Tests on three American blind patients – two men and a woman- who were legally blind produced exciting results according to Olav Hellebo, CEO of UK bio-tech Firm ReNeuron in Bridgend ,Wales. Before the procedure the three could read only the largest group of letter on a special eye test chart, as they had retinitis…